Navigation Links
Improved characterization of nanoparticle clusters for EHS and biosensors research
Date:10/26/2011

The tendency of nanoparticles to clump together in solution"agglomeration"is of great interest because the size of the clusters plays an important role in the behavior of the materials. Toxicity, the persistence of the nanomaterials in the environment, their efficacy as biosensors and, for that matter, the accuracy of experiments to measure these factors, are all known to be affected by agglomeration and cluster size. Recent work* at the National Institute of Standards and Technology (NIST) offers a way to measure accurately both the distribution of cluster sizes in a sample and the characteristic light absorption for each size. The latter is important for the application of nanoparticles in biosensors.

A good example of the potential application of the work, says NIST biomedical engineer Justin Zook, is in the development of nanoparticle biosensors for ultrasensitive pregnancy tests. Gold nanoparticles can be coated with antibodies to a hormone** produced by an embryo shortly after conception. Multiple gold nanoparticles can bind to each hormone, forming clusters that have a different color from unclustered gold nanoparticles. But only certain size clusters are optimal for this measurement, so knowing how light absorbance changes with cluster size makes it easier to design the biosensors to result in just the right sized clusters.

The NIST team first prepared samples of gold nanoparticlesa nanomaterial widely used in biologyin a standard cell culture solution, using their previously developed technique for creating samples with a controlled distribution of sizes***. The particles are allowed to agglomerate in gradually growing clusters and the clumping process is "turned off" after varying lengths of time by adding a stabilizing agent that prevents further agglomeration.

They then used a technique called analytical ultracentrifugation (AUC) to simultaneously sort the clusters by size and measure their light absorption. The centrifuge causes the nanoparticle clusters to separate by size, the smaller, lighter clusters moving more slowly than the larger ones. While this is happening, the sample containers are repeatedly scanned with light and the amount of light passing through the sample for each color or frequency is recorded. The larger the cluster, the more light is absorbed by lower frequencies. Measuring the absorption by frequency across the sample containers allows the researchers both to watch the gradual separation of cluster sizes and to correlate absorbed frequencies with specific cluster sizes.

Most previous measurements of absorption spectra for solutions of nanoparticles were able only to measure the bulk spectrathe absorption of all the different cluster sizes mixed together. AUC makes it possible to measure the quantity and distribution of each nanoparticle cluster without being confounded by other components in complex biological mixtures, such as proteins. The technique previously had been used only to make these measurements for single nanoparticles in solution. The NIST researchers are the first to show that the procedure also works for nanoparticle clusters.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology news :

1. Improved living environments can reduce health problems for women and children
2. Breeding soybeans for improved feed
3. First proof in patients of an improved magic bullet for cancer detection and radio-therapy
4. Improved method for capturing proteins holds promise for biomedical research
5. U of M researchers use improved imaging technique; discover a better approach to diagnosing epilepsy
6. Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients
7. New genetic map of potato may lead to improved crops
8. Nanowire-based sensors offer improved detection of volatile organic compounds
9. China needs improved administrative system for nuclear power safety
10. IOF calls for improved strategies to close the treatment gap and reduce future burden of fractures
11. NPL helps Senceive to offer improved monitoring of structural assets across the UK
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Improved characterization of nanoparticle clusters for EHS and biosensors research
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... FL (PRWEB) , ... October ... ... (RPS®) today announces publication of a United States multicenter, prospective clinical study ... use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial ...
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
Breaking Biology Technology: